Mayne Pharma (ASX:MYX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Mayne Pharma (ASX:MYX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Application for quotation of securities - MYX
2026 Full Year Results Investor Presentation
Mayne Pharma FY26 revenue down 6%, underlying EBITDA down 27%, strong DistributeRx launch
2026 Corporate Governance Statement and Appendix 4G
2026 Full Year Results Media Release
Mayne Pharma FY26 revenue down 6% with strong Women's Health growth and DistributeRx launch
2026 Appendix 4E and Annual Report
Mayne Pharma returns to profit with $24.5 million net income in FY2026 on lower revenue
Notification of date for release of FY26 results
Upcoming presentation of Imvexxy clinical data
Mayne Pharma launches Investor Hub
Initial Director's Interest Notice
Mayne Pharma Bioshares Summit Presentation
Notification of cessation of securities - MYX
Notification regarding unquoted securities - MYX
Non-Executive Director appointment
Mayne Pharma to present at the 20th Bioshares Summit
Mayne Pharma reports unaudited Q4 and FY26 results
Mayne Pharma reports 6% revenue decline in FY26 with strong Women’s Health growth and DistributeRx expansion
Mayne Pharma appoints new Chief Financial Officer
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Initial Director's Interest Notice
Mayne Pharma appoints new Non-Executive Director
Change in substantial holding
Change in substantial holding
Final Director's Interest Notice